Quarterly report · Q3
9265.TEDINET S100QJ7N
Period2022-06-01 → 2023-02-28
Filed2023-04-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥41.7bn | 2022-06-01 → 2023-02-28 | Cons. | Net sales |
| Revenue | ¥55.1bn | 2021-06-01 → 2022-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥40.6bn | 2021-06-01 → 2022-02-28 | Cons. | Net sales |
| Operating income | ¥895m | 2022-06-01 → 2023-02-28 | Cons. | Operating income |
| Operating income | ¥852m | 2021-06-01 → 2022-02-28 | Cons. | Operating income |
| Ordinary income | ¥936m | 2022-06-01 → 2023-02-28 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2021-06-01 → 2022-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥907m | 2021-06-01 → 2022-02-28 | Cons. | Ordinary income |
| Profit before tax | ¥333m | 2022-06-01 → 2023-02-28 | Cons. | Income before income taxes |
| Profit before tax | ¥923m | 2021-06-01 → 2022-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥1m | 2022-06-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥696m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥592m | 2021-06-01 → 2022-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥3m | 2022-06-01 → 2023-02-28 | Cons. | Profit loss |
| Net income | ¥591m | 2021-06-01 → 2022-02-28 | Cons. | Profit loss |
| Total assets | ¥22.5bn | at 2023-02-28 | Cons. | Assets |
| Total assets | ¥24.1bn | at 2022-05-31 | Cons. | Assets |
| Total assets | ¥23.9bn | at 2022-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥14.8bn | at 2023-02-28 | Cons. | Liabilities |
| Total liabilities | ¥16.1bn | at 2022-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥7.7bn | at 2023-02-28 | Cons. | Net assets |
| Net assets / equity | ¥8.0bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥7.9bn | at 2022-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.3bn | at 2023-02-28 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.0bn | at 2022-05-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥0.46 | 2022-06-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥79.44 | 2022-12-01 → 2023-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥272.67 | 2021-06-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥232.03 | 2021-06-01 → 2022-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥47.21 | 2021-12-01 → 2022-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 34.2% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.9% | at 2022-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-06-01 → 2023-02-28 | −¥11m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-06-01 → 2023-02-28 | −¥11m |
| Reconciling Itemsreconciling | segment profit | 2022-06-01 → 2023-02-28 | −¥690m |
| jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥211m |
| jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥211m |
| jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2022-06-01 → 2023-02-28 | ¥0 |
| jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥10m |
| jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥41.5bn |
| jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥41.5bn |
| jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segment | revenue intersegment | 2022-06-01 → 2023-02-28 | ¥11m |
| jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥1.6bn |
| jpcrp040300-q3r_E33393-000Medical Mallreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥50m |
| jpcrp040300-q3r_E33393-000Medical Mallreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥50m |
| jpcrp040300-q3r_E33393-000Medical Mallreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥0 |
| —segment total | revenue | 2022-06-01 → 2023-02-28 | ¥41.7bn |
| —segment total | revenue external | 2022-06-01 → 2023-02-28 | ¥41.7bn |
| —segment total | revenue intersegment | 2022-06-01 → 2023-02-28 | ¥11m |
| —segment total | segment profit | 2022-06-01 → 2023-02-28 | ¥1.6bn |
| Reconciling Itemsreconciling | revenue | 2021-06-01 → 2022-02-28 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2021-06-01 → 2022-02-28 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2021-06-01 → 2022-02-28 | −¥658m |
| jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue | 2021-06-01 → 2022-02-28 | ¥214m |
| jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2021-06-01 → 2022-02-28 | ¥214m |
| jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2021-06-01 → 2022-02-28 | ¥0 |
| jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2021-06-01 → 2022-02-28 | ¥12m |
| jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segment | revenue | 2021-06-01 → 2022-02-28 | ¥40.4bn |
| jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segment | revenue external | 2021-06-01 → 2022-02-28 | ¥40.4bn |
| jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segment | revenue intersegment | 2021-06-01 → 2022-02-28 | ¥0 |
| jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segment | segment profit | 2021-06-01 → 2022-02-28 | ¥1.5bn |
| jpcrp040300-q3r_E33393-000Medical Mallreportable segment | revenue | 2021-06-01 → 2022-02-28 | ¥51m |
| jpcrp040300-q3r_E33393-000Medical Mallreportable segment | revenue external | 2021-06-01 → 2022-02-28 | ¥51m |
| jpcrp040300-q3r_E33393-000Medical Mallreportable segment | segment profit | 2021-06-01 → 2022-02-28 | −¥7m |
| —segment total | revenue | 2021-06-01 → 2022-02-28 | ¥40.6bn |
| —segment total | revenue external | 2021-06-01 → 2022-02-28 | ¥40.6bn |
| —segment total | revenue intersegment | 2021-06-01 → 2022-02-28 | ¥0 |
| —segment total | segment profit | 2021-06-01 → 2022-02-28 | ¥1.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 360
| Item | Context | Value | Unit |
|---|---|---|---|
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E33393-000MedicalMallReportableSegmentsMember | 50000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 41725000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 41725000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E33393-000MedicalEquipmentSalesReportableSegmentsMember | 11000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E33393-000MedicalEquipmentManufacturingAndSalesReportableSegmentMember | 0 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E33393-000MedicalMallReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 11000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -11000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E33393-000MedicalEquipmentSalesReportableSegmentsMember | 41475000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E33393-000MedicalEquipmentManufacturingAndSalesReportableSegmentMember | 211000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E33393-000MedicalMallReportableSegmentsMember | 50000000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 41737000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -11000000 | JPY |
| Net sales | CurrentYTDDuration | 41725000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E33393-000MedicalEquipmentSalesReportableSegmentsMember | 1574000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E33393-000MedicalEquipmentManufacturingAndSalesReportableSegmentMember | 10000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E33393-000MedicalMallReportableSegmentsMember | 0 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 1586000000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -690000000 | JPY |
| Operating income | CurrentYTDDuration | 895000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)福岡財務支局長 | |
| Filing date cover page | FilingDateInstant | 2023-04-14 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第６期第３四半期(自 2022年12月１日 至 2023年２月28日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)ヤマシタヘルスケアホールディングス株式会社 | |
| Company name in english cover page | FilingDateInstant | YAMASHITA HEALTH CARE HOLDINGS,INC. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役 執行役員 社長 山 下 尚 登 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)福岡市博多区下川端町２番１号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)092－402－2922（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役 執行役員 北 野 幸 文 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)福岡市博多区下川端町２番１号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)092－402－2922（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役 執行役員 北 野 幸 文 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E33393 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 92650 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)ヤマシタヘルスケアホールディングス株式会社 | |
| Filer name in english | FilingDateInstant | YAMASHITA HEALTH CARE HOLDINGS, INC. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |